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IDENTIFICATION OF THE TIDEMARK LINE OF CALCIFICATION IN
OSTEOARTHRITIC CARTILAGE USING A STAIN FOR ALKALINE
PHOSPHATASE
C.S. Black, P.K. Crepeau, I.D. Shefﬁeld, J.R. Macdonald, D.J. Wootton,
M. Baek, D.L. Eggett, P.R. Reynolds, D.L. Kooyman. Brigham Young Univ.,
Provo, UT, USA
Purpose:While osteoarthritis (OA) has traditionally been classiﬁed as a
“wear and tear” disease, recent studies have shown that this disease is
due to an inﬂammatory response. Our lab has made signiﬁcant strides
in identifying key biomarkers that are present throughout the pro-
gression of OA. In past histochemical staining, we and others have
noticed a faint line located between the subchondral bone and the
articular surface in knee joints, presumed to be the tidemark or line of
demarcation between calciﬁed and uncalciﬁed cartilage. This would
suggest that cartilage in osteoarthritic joints is lost in part due to a
metabolic calciﬁcation process. The purpose of this study is to prove
quantitatively that the faint line is the tidemark and not simply an
artifact of the staining process.
Methods: Mouse knees (n ¼ 8) were embedded and stained for both
Alkaline Phosphatase (ALP) and Safranin-O/Fast Green (Saf-O, FG). ALP,
a metallo hydrolase enzyme that is active during tissue calciﬁcation,
was used to identify the true location of the tidemark. Using Adobe
Photoshop, pictures from the two stains were overlaid for tidemark
comparison. A standard-sized box was cropped over the two pictures
and the “lasso” tool was used to outline the area between the articular
surface and the tidemark in each stain. The area of each of the outlined
pictures was then calculated in order to compare the tidemark location
between the two stains. To ensure that the anatomy was nearly iden-
tical between samples and that speciﬁc anatomical landmarks would
match up when overlaid, the comparison was only made between
consecutive slides taken from the same sample. Data were analyzed
using a paired T-test.
Results: A comparison of the areas outlined in both stains resulted in a
T-value of 0.51 that equated to a P-value greater than 0.6 with a
standard deviation of 5.87%. Thus, we can conclusively say that the thin
line observed in the Safranin-O/Fast Green stain is indeed the tidemark
line of calciﬁcation we see in the Alkaline Phosphatase stain.
Conclusions: Proving that the thin line observed between subchondral
bone and the articular surface after Saf-O, FG staining is the tidemark
demarcation of calciﬁcation and not an artifact is important. It allows us
and others to compare the progression of the tidemark over multiple
age groups and/or models using the simple Saf-O, FG stain. It lends
support to the idea that OA is not simply a “wear and tear” disease.
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INTRA-CARTILAGE DELIVERY OF DEXAMETHASONE FROM AVIDIN, A
CATIONIC DRUG CARRIER, ATTENUATES INJURY INDUCED CATABOLIC
EFFECTS IN KNEE JOINTS OF MATURE RABBITS IN VIVO
A.G. Bajpayee y, A. Scheu z, R.D. Vega x, N.H. Varady y, I.A. Yannatos 4,
R.M. Porter x, A.J. Grodzinsky y. yMIT, Cambridge, MA, USA; zClínica
Alemana de Santiago, Santiago, Chile; xBIDMC, Boston, MA, USA; k Tufts
Univ., Medford, MA, USA
Purpose: Avidin (Av), a positively charged protein, exhibits ideal
characteristics for targeted i.a drug delivery into cartilage due to
its small-enough size (66kDa) and optimal net charge (between
þ6 & þ20). The high concentration of negatively charged proteo-
glycans inside cartilage offers a high site density (Nt¼2920mM) for
Av binding. In previous studies with cartilage explants, this
property of weak-reversible binding allowed Av to penetrate
through full thickness of cartilage yet have a long retention time.
Donnan partitioning of Av suggested at least a six-fold upward
partitioning factor at the synovial ﬂuid-tissue interface. This would
result in a steep intra-tissue concentration gradient that would
signiﬁcantly enhance its transport rate and uptake. We therefore
hypothesized that the relatively weak but reversible nature of
electrostatic Av binding to GAGs inside cartilage would enable a
long half-life (t1/2) of Av when injected i.a into rabbit knee joints
in-vivo. Functionalization of drugs to Av could thereby provide a
unique targeted intra-cartilage delivery mechanism.Dexamethasone (DEX) in low doses is known to suppress cyto-
kine-induced catabolic effects. Av-DEX conjugations were synthe-
sized to enable sustained release of DEX inside cartilage. Here, we
show that only a single dose Av-DEX is enough to suppress IL-1
induced GAG loss over 3 weeks in-vitro. Additionally, we evaluated
therapeutic efﬁcacy of Av-DEX in a rabbit ACLT model of PTOA and
compare it with soluble DEX
Methods: In-vitro bioactivity of Av-DEX: Calf cartilage explants were
cultured in Lg DMEM containing IL-1(1ng/ml) with 1 time dose of 3
types of Av-DEX compounds: X (fast release ester linker, t1/2¼ 15h),
Y (slow release hydrazone, t1/2 ¼58h), Z (1:1 molar ratio of X & Y)
& soluble DEX (100mM) for 22 days. sGAG loss was measured by
DMMB assay. In vivo rabbit studies (approved by IACUC BIDMC): In
one study, right knee joints of twelve 12m old New Zealand rabbits
were i.a injected with Av-red. After 1d, 4d & 7d rabbits were sac-
riﬁced. Av uptake-retention was measured in following joint tissues
using plate reader: lateral & medial tibia cartilage (LTC, MTC);
femoral cartilage (LFC, MFC); groove & patella cartilage (GCþPC);
cruciate ligaments (ACL, PCL); menisci (LM, MM); patella, quadriceps
& extensor tendons (PT, QT, ET). In a second study, 60 rabbits
underwent ACL transection (ACLT). Contralateral left knees were
used as operated controls. 1w after surgery, ACLT knees were
injected with 600ml of saline, soluble DEX & Av-DEX (Z, 0.5mg DEX);
N¼10 rabbits each treatment. Rabbits were euthanized at 3w or 9w
post-surgery. Gross morphology of joints was assessed qualitatively
& by histology for osteophytes, soft tissue ﬁbrillation & lesions.
Articular cartilage was examined for expressions of IL-1b, ACAN,
Col2, MMP-1 & 3(qPCR, normalized by GAPDH). Static & dynamic
equilibrium moduli were measured on LTC by applying ramp-hold
displacements and sinusoidal waveform respectively using mechan-
ical spectrometer. Collagen content was measured by hydroxyproline
assay
Results: 1 dose Av-DEX suppressed IL-1 induced GAG loss from
cartilage by a signiﬁcantly greater amount than soluble DEX (Fig 1A).
Fig 1B-C compares retention of Av-red in rabbit knee post 24h i.a
injection with that in untreated control knees; by comparison, no
traces of the same-size electrically neutral version of Av were found.
Fig 1D shows Av half-life as a function of square of tissue thickness
& GAG content; longest t1/2 of 154h was measured in the thickest
cartilage, LTC. Fig 2A-C show mRNA expressions in rabbit cartilage
3w post ACLT surgery. IL-1b, MMP-1 & ACAN expressions were
signiﬁcantly suppressed with Av-DEX treatment compared to oper-
ated control and soluble DEX. Treatment with DEX or Av-DEX did
not restore ACLT induced loss of tissue stiffness (Fig 2D). Collagen
content remained unchanged (Fig 2E), however, GAG content
reduced in Av-DEX treated patellar cartilage compared to control
(Fig 2F)
Conclusions: Av has the unique property to rapidly diffuse into carti-
lage deep zones and remain bound for extended time periods in vivo.
No other such structures have been demonstrated yet for i.a injected
intra-cartilage drug delivery. Av-DEX effectively suppressed IL-1
induced catabolic effects in-vitro and in vivo (rabbits) over 3w. Data
collection for 9w study is underway.
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ADHESIVE BARRIER/DIRECTIONAL CONTROLLED RELEASE FOR
CARTILAGE REPAIR BY ENDOGENOUS PROGENITOR CELL
RECRUITMENT
G.-I. Im, J.-M. Lee, E.-A. Kim. Dongguk Univ. Ilsan Hosp., Goyang, Republic
of Korea
Purpose: Implantation of the therapeutic depot is typical methods in
tissue regeneration studies, but importantly, we developed an direc-
tional ‘releasing-to’ approach by applying an adhesive gel patch (chi-
tosan-catechol, CHI-C) on top of the ﬁbrin gel, which plays a role in
releasing the encapsulated PDGF-AA only to bone marrow direction for
maximizing MSC cell migration. Furthermore, the migrated cells are
retained on the defect site by the adhesive chitosan-catechol barrier.
The purpose of this study is to introduce the concept of the adhesive
barrier/directional controlled release and prove its efﬁcacy through an
in vivo tracking model.
Methods: 12 week-old male nude rats were anesthetized with zoletil
and xylazine. A 1.5 mm outer diameter trephine drill was employed
to create osteochondral defects (2.0  2.0 mm) in the trochlear
groove of the femur. A hole was created inside the defect using a 26-
gauge needle and deepened until blood gushed out. 1.0  106 MSCs
suspended in 10 ml PBS was mixed with BD Matrigel of the same
volume as described previously [1]. The mixture was then slowly
injected into the marrow cavity. And then, the osteochondral defects
were ﬁlling with PDGF-AA-loaded HCF and sealed once more with
CHI-C adhesive.
Results: Experimental set-up to demonstrate directional release of
bioactive molecules from HCF hydrogel is shown in Fig. 1A. Rho-Dex
was released only to the right side direction for two days (Fig. 1B).
Also, the CHI-C gel patch can be used to prevent the cell migrations.
The design of experiment was illustrated as shown in Fig. 1C. The CHI-
C gel patch was placed in the middle of a 6-well plate (up panel) to
divide the space into two regions. NIH3T3 cells were seeded and cul-
tured only to the upper area (middle panel). The optical images were
collected after 12 h of the cell incubations. Fig. 1D shows the uniform
spindle morphology of NIH3T3 cells on a cell-seeded space in the
upper well plate. In the interface between the cell-seeded space andCHI-C barriers, unattached, round-shape NIH3T3 cells were observed
(Fig. 1E). In the opposite site, the interface between the CHI-C barriers
and the media-applied plate, we could not found any NIH3T3 cells
(Fig. 1F and G). In vivo bioluminescence imaging was performed in
transplanted animals for 14 days. In the HCF-only Group without
PDGF-AA (Group 1), the majority of the injected MSCs remained in the
marrow cavity for 7 days. On the other hand, Groups 2 (plugged with
PDGF-AA-loaded HCF) and 3 (plugged with PDGF-AA and TGF-b1-
loaded HCF) showed a time-dependent movement of injected cells
toward the osteochondral defect. Interestingly, Group 4, in which
osteochondral defects were sealed with CHI-C barrier, showed faster
and greater movement of injected cells than other groups. Also, che-
motactic potentials of Group 4 were maintained for 14 days while the
cell migration was stopped within 7 days in other groups. On day 14,
all the signals in Group 4 congregated at the osteochondral defect
(Fig. 2B). After the animals were sacriﬁced at six week of trans-
plantation, the femora were removed from the bodies and the far-red
ﬂuorescence signals were detected again (Fig. 2C). The ﬂuorescent
signals were detected in the osteochondral defect area in Groups 2, 3
and 4, whereas they were not detected in Group 1 (HCF-only Group).
The total ﬂuorescence signal in the femurs of Group 4 was 5.9-fold
stronger than that of Group 1 (p < 0.05), 2.7-fold stronger than that of
Group 2 (p < 0.05) and 2.5-fold stronger than that of Group 3 (p <
0.05) (Fig 2D).
Conclusions: We developed a novel system for osteochondral repair
using directional bio-adhesive gel patch and growth factor-loaded HCF
in which the CHI-C barrier induced a directional release of growth
factors and blocked the dispersion of the migrated MSCs from the
osteochondral bone region to other tissues. We conﬁrmed that the CHI-
C barrier enhanced the migration of MSCs to the osteochondral defect
and induced better cartilage repair. This system is expected to make a
signiﬁcant contribution in cartilage tissue engineering without cell
transplantation.
